- Solventum is a leading medical device manufacturer based in Maplewood, Minnesota, specializing in sterilization devices, wound care products, and surgical equipment, with reported sales of $2 billion in Q4 2025.
- In the past year, Solventum has reported a 3.5% organic sales growth and introduced full-year guidance for 2026, indicating a strong recovery and transformation strategy under CEO Bryan Hanson.
- The company's MedSurg business, which includes wound dressings and surgical equipment, generated over $1.24 billion in revenue during Q4 2025, showcasing strong demand and market presence.
- Ideal buyers for Solventum's products are healthcare providers and hospitals seeking reliable and innovative solutions for wound care and sterilization, addressing critical needs in patient care and operational efficiency.
Solventum's workforce is organized into 18 departments, with a significant concentration in Operations, which employs 561 individuals. Information Technology and Sales follow, with headcounts of 397 and 313, respectively. This distribution indicates a strong emphasis on operational efficiency and technological support, essential for maintaining competitiveness in the medical products sector. The diversity in departments, including Health Services and Community and Social Services, reflects the company's commitment to holistic healthcare solutions.
The company's workforce is geographically distributed across 371 locations, with the highest concentration in Saint Paul, housing 576 employees. Minneapolis, MN, and San Antonio, TX, follow with 98 and 89 employees, respectively. The substantial headcount in 'Other' locations, totaling 1,429, suggests a significant remote or distributed workforce, indicating Solventum's broad operational reach and adaptability across various regions.
